Abstract:Infection-related GN encompasses a range of clinical entities and outcomes. Unlike acute poststreptococcal GN in children, the prognosis of bacterial infection–related GN in adults is often poor (1). Up to one half of patients will develop persistent kidney impairment, and one third will progress to kidney failure (2). Bacterial infection–related GN is more common in developing countries, where the consequences of CKD can be particularly difficult to manage (3). Multiple dynamic factors contribute to bacterial infection–related GN etiology and natural history. In addition to inherited characteristics that predispose to immune-mediated diseases, pathogen prevalence and virulence as well as access to adequate health care services contribute to bacterial infection–related GN incidence and severity. Furthermore, bacterial infection–related GN treatment is complicated by increasing frequency and a spectrum of antibiotic drug resistance (2). The epidemiology of bacterial infection–related GN is location and time specific, which limits the relevance of research from different eras or regions. The effectiveness of health care strategies and patient management protocols depends on understanding factors associated with disease severity and treatment response. Consequently, there is urgent unmet need for adult bacterial infection–related GN research, particularly in developing countries. The observational retrospective cohort study by John et al. (4) in this issue of CJASN provides valuable insights into the epidemiology of adult bacterial infection–related GN in India and highlights a number of research areas that demand urgent attention. From retrospective review of 15,000 native kidney biopsies performed over 10 years, the authors identified and analyzed over 500 cases of adult bacterial infection–related GN (4). The study population is almost five times bigger than that in the next largest cohort study of infection-related GN in adults (1). Additional to the impressive study size, the use of novel subcohort definitions allowed the authors to identify characteristics that associated with kidney disease severity. The authors used the relative timing of GN presentation and infection to categorize cases. Latency was defined as parainfectious if the GN was diagnosed at the time of active infection, periinfectious if the GN occurredwithin 1–7 days of infection, or postinfectious if there were at least 7 days between infection resolution and onset of GN (4). Parainfectious GN latency was independently associated with progression to kidney failure after multivariable analysis (4). Interestingly, the parainfectious cohort was different from the periand postinfectious GN subgroups in a number of baseline criteria. The parainfectious GN cohort was characterized by more equal sex distribution, higher prevalence of diabetes, lower eGFR at biopsy, longer duration from clinical GN onset to kidney biopsy, and more frequent and severe interstitial fibrosis and tubular atrophy on biopsy (4). The parainfectious cohort also suffered different infections from the periand postinfection cohorts; urinary tract infection (UTI) was the most common infection site, nonstreptococcal organisms were more common, and almost all of the drug-resistant organismswere isolated from the parainfectious subcohort (4). These findings suggest that parainfectious GN is a distinct and severe clinical entity characterized by nonstreptococcal, drug-resistant organisms causing UTI, with rapid onset of GN and significantly reduced eGFR in patients with diabetes. Of course, like all retrospective cohort research, this study is unable to attribute causation, and conclusions should be made cautiously. The findings could be confoundedbyunaccounted practical factors. For example, UTI-associated GN might present diagnostic difficulties that contributed to diagnostic delay and poor outcomes in the parainfectious subgroup. Nevertheless, by raising awareness of the parainfectious GN phenotype, this study should affect and improve clinical care. The article by John et al. (4) raises a number of other important issues. Electron microscopy was unavailable for the vast majority of patients and therefore was not used for bacterial infection–related GN diagnosis (4). This might be seen as a limitation of cohort uniformity and reliability. However, it also highlights the restricted accessibility of electron microscopy globally and the need to develop novel diagnostic techniques. The authors identified associations between renin-angiotensin blockade and survival Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry

Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19

COVID-19 and kidney: role of SARS-CoV-2 infection in the induction of renal damage

Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study

Kidney Dysfunction and Its Progression in Patients Hospitalized Duo to COVID-19: Contribution to the Clinical Course and Outcomes

Unmasking the Silent Threat: COVID-19's Pervasive Impact on Renal Allografts

Are patients with Covid-19 at risk of long-term chronic kidney disease?

High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy

Kidney Function Tests and Continuous eGFR Decrease at Six Months after SARS-CoV-2 Infection in Patients Clinically Diagnosed with Post-COVID Syndrome

COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney Outcomes

Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

Glomerulonephritis following COVID-19 infection or vaccination: a multicenter study in South Korea

Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study

Short-Term Outcomes of Infection-Related Glomerulonephritis in Diabetes Mellitus

Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study

New Insights into Epidemiology and Outcome of Bacterial Infection-Related Glomerulonephritis.

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection

Analysis of the impact of various risk factors on short-term and long-term outcomes in patients with COVID-19 on maintenance hemodialysis